SCHEMBL13426201

SCHEMBL13426201

CN1c2ccccc2CCc2ccc(-c3c4cc(N5CCCCC5)ccc4c(-c4cccc5ccccc45)c4cc(N5CCCCC5)ccc34)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
ALK Q9UM73 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
HTR6 P50406 3/20 0.33
AVPR2 P30518 2/20 0.33
MET P08581 1/20 0.33
HTR1A P08908 2/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR7 P34969 2/20 0.33
DRD3 P35462 2/20 0.33
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
DRD4 P21917 1/20 0.33
DHODH Q02127 1/20 0.33
PRKDC P78527 1/20 0.32
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426193 0.94 ALK (0.34) SLC6A2SLC6A4SLC6A3ALKHTR6
SCHEMBL13425861 0.90 AVPR2 (0.39) SLC6A2SLC6A4SLC6A3HTR6AVPR2
SCHEMBL13426087 0.88 HTR3A (0.41) SLC6A2SLC6A4SLC6A3HTR6AVPR2
SCHEMBL13425988 0.87 KIF11 (0.38) SLC6A2SLC6A4SLC6A3HTR6AVPR2
SCHEMBL13426194 0.87 MAOA (0.36) SLC6A2SLC6A4SLC6A3ALKMET
SCHEMBL13488285 0.84 CYP11B1 (0.37) SLC6A4CYP11B1CYP11B2HTR1AHTR2A
SCHEMBL13426348 0.84 PDK2 (0.37) ALKHTR6AVPR2DRD3IDO1
SCHEMBL13425831 0.84 HSD17B10 (0.37) SLC6A2SLC6A4SLC6A3HTR6AVPR2
SCHEMBL13426071 0.82 HTR3A (0.41) SLC6A2SLC6A4SLC6A3HTR6MET
SCHEMBL13426257 0.82 AVPR2 (0.36) SLC6A2SLC6A4SLC6A3HTR6AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A SLC6A2 1637/4885SLC6A4 2579/4885SLC6A3 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.